Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 25 min ago
PreprintCC BYarXiv (Cornell University)

Stochastic First-Passage Theory of HIV Viral Rebound Following Latent Reservoir Reactivation

Abstract

In our earlier work, we modeled the stochastic initiation of HIV rebound by treating latent-cell reactivation as a Poisson-driven process during antiretroviral-therapy (ART) washout, immune modulation, and therapeutic perturbation~\cite{Taye2025CM}. That framework characterized activation survival, cumulative hazards, waiting-time laws, and expected viral-load trajectories. However, the endpoint observed in analytical treatment interruption (ATI) studies is not the hidden time of first successful reactivation. It is the first time at which plasma virus exceeds an assay-defined detection threshold. Here we reformulate post-treatment rebound as a stochastic first-passage problem, with Treb=inf{t≥ tw:V(t)≥ Vdet}. Successful reactivation events arrive with a time-dependent intensity, and each event seeds an exponentially expanding viral lineage. The total plasma viral load is therefore a Poisson shot-noise process, and rebound corresponds to its first threshold crossing. In the rare-reactivation regime, this crossing is dominated by the earliest successful lineage. Rebound timing then separates into two components: a stochastic waiting time for reservoir reactivation and a deterministic growth delay to detectability. This separation gives a shifted-hazard survival law and yields closed-form rebound-time distributions for constant activation, ART-washout-dependent activation, immune-periodic activation, Cox-process activation, and heterogeneous-reservoir activation. The same formulation also provides a likelihood suitable for the interval-censored sampling structure of ATI trials.

Related

  1. Variability of human immunodeficiency virus-1 in the female genital reservoir during genital reactivation of herpes simplex virus type 2
    J. Legoff, P. Roques, M.-A. Jenabian +8
    Clinical Microbiology and InfectionPeer-reviewedLicence not statedFull text4 citedMicrobiologyHAL
  2. NK cells engineered with a chimeric antigen receptor delay HIV rebound and reshape HIV reservoir composition
    Yuan Shi, Izra Abbaali, William Harvey +10
    Nature CommunicationsPeer-reviewedCC BY 4.0Full textMicrobiologyCrossref
  3. Inhibitory potential of autologous neutralizing antibodies sets quantitative limits on the rebound-competent HIV-1 reservoir
    Mauro A. Garcia, Anna Farrell-Sherman, Beril Aydin +22
    Proceedings of the National Academy of SciencesPeer-reviewedCC BY-NC-ND6 citedMicrobiologyOpenAlex
  4. Stochastic Field Theory of HIV Latency: Instanton Dynamics and the Path to Viral Rebound
    Jose de Jesus Bernal-Alvarado, David Delepine, Georges Delepine
    arXivPreprintCC BY 4.0Full textEvolutionary biologyBiological & medical physicsarXiv
  5. Case Report: Diagnostic dilemma: rebound thymic hyperplasia mimicking mediastinal relapse following chemoimmunotherapy in pediatric jejunal Burkitt lymphoma
    Meifang Lin, Zengwang Zhang, Hao Zhang +1
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyCrossrefEurope PMCEurope PMCPMC
BibTeX
@misc{taye2026stochastic,
  title = {{Stochastic First-Passage Theory of HIV Viral Rebound Following Latent Reservoir Reactivation}},
  author = {Mesfin Asfaw Taye},
  howpublished = {arXiv (Cornell University)},
  year = {2026},
  month = jul,
  doi = {10.48550/arxiv.2607.04910},
  url = {https://arxiv.org/abs/2607.04910},
  note = {CC BY},
}
RIS
TY  - UNPB
TI  - Stochastic First-Passage Theory of HIV Viral Rebound Following Latent Reservoir Reactivation
AU  - Mesfin Asfaw Taye
PY  - 2026
DA  - 2026/07/06
PB  - arXiv (Cornell University)
DO  - 10.48550/arxiv.2607.04910
UR  - https://arxiv.org/abs/2607.04910
AB  - In our earlier work, we modeled the stochastic initiation of HIV rebound by treating latent-cell reactivation as a Poisson-driven process during antiretroviral-therapy (ART) washout, immune modulation, and therapeutic perturbation~\cite{Taye2025CM}. That framework characterized activation survival, cumulative hazards, waiting-time laws, and expected viral-load trajectories. However, the endpoint observed in analytical treatment interruption (ATI) studies is not the hidden time of first successful reactivation. It is the first time at which plasma virus exceeds an assay-defined detection threshold. Here we reformulate post-treatment rebound as a stochastic first-passage problem, with T_reb=inf{t≥ t_w:V(t)≥ V_det}. Successful reactivation events arrive with a time-dependent intensity, and each event seeds an exponentially expanding viral lineage. The total plasma viral load is therefore a Poisson shot-noise process, and rebound corresponds to its first threshold crossing. In the rare-reactivation regime, this crossing is dominated by the earliest successful lineage. Rebound timing then separates into two components: a stochastic waiting time for reservoir reactivation and a deterministic growth delay to detectability. This separation gives a shifted-hazard survival law and yields closed-form rebound-time distributions for constant activation, ART-washout-dependent activation, immune-periodic activation, Cox-process activation, and heterogeneous-reservoir activation. The same formulation also provides a likelihood suitable for the interval-censored sampling structure of ATI trials.
SN  - 2331-8422
ER  -